Skip to content
NYSE · PLASTIC MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS · LARGE CAP

DuPont de Nemours, Inc. DD

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$6.8B
▲ 1.9% YoY
$-779.0M
▼ 210.8% YoY
$227.0M
▼ 52.7% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

DuPont de Nemours, Inc. provides advanced solutions across healthcare, water, construction and industrial markets. At December 31, 2025, it had subsidiaries in about 50 countries worldwide and manufacturing operations in about 20 countries. Following a fourth-quarter 2025 segment realignment, it reports its financial results in two reportable segments: Healthcare & Water Technologies and Diversified Industrials. Its Healthcare & Water Technologies segment includes high-performance packaging and parts and components for medical device and biopharma markets, as well as water filtration and purification technologies for industrial wastewater and energy, municipal drinking water and desalination, and life sciences and specialty markets. Its Diversified Industrials segment includes building technologies serving new-build and repair/remodel applications across non-residential and residential construction markets, and industrial technologies comprising adhesive, wear and friction, and packaging solutions for aerospace, automotive and printing and packaging markets. At December 31, 2025, it owned about 6,100 patents and patent applications globally, of which about 4,700 were associated with its continuing operations. DuPont de Nemours, Inc. is a Delaware corporation formed in 2015, formerly named DowDuPont Inc., for the purpose of effecting the all-stock merger of equals between The Dow Chemical Company and E. I. du Pont de Nemours and Company, which became effective on August 31, 2017.

Written from the business description in DuPont de Nemours, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 17 February 2026. Every sentence was checked against that document before publication.

Growth

USD 6.8B
Revenue, FY2025 · full 11-year series below
Revenue $B Net income $B
FY2025 · Revenue 6.8 · Net income -0.8
20B40B
20152018202120242025
Compound annual growth
−19.3%
−9.3%
+2.7%
+3.6%
−2.9%
−10.8%
−16.0%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −9.3% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−11 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating 2.9% · Net -10.8%
20%40%-10%-20%
201520202025
ROE
FY2025 · ROE -4.2%
10%20%-2%-4%-6%
201520202025
Three returns, three denominators.
Return on capital employedNot available: we don't have a clean operating profit figure for this period.

Each USD of equity lost 4 cents this year.

Cash & shareholders

USD 597.0M
returned in FY2025 · dividends + net buybacks
Free cash flow $B
FY2025 · FCF 0.2
1.5B3.0B-2.5B-5.0B
201520202025
Net buybacks $B Dividends $B
FY2025 · Dividends 0.6 · Net buybacks ·
3B6BDividendsNet buybacks
201520172019202120232025

USD 597.0M in dividends went back to shareholders in a year without profit.

Total assetsUSD 21.6B
EquityUSD 13.9B
CashUSD 715.0M
Gross debtUSD 3.1B
Net debtUSD 2.4B
Current ratio2.42×

Net debt stands at 17% of equity.

The 11-year record

11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
DD, 11-year financial record
Metric 20252024202320222021202020192018201720162015
Revenue $B6.86.76.613.012.611.115.422.611.748.248.8
Operating income $B0.20.1−0.31.41.4−1.3−0.10.6−1.54.49.9
EBITDA $B0.80.80.32.62.61.83.12.8−0.57.312.5
Income tax $B0.10.2−0.20.40.20.1−0.00.2−1.80.02.1
Net income $B−0.80.70.45.96.5−3.00.53.81.24.37.7
Free cash flow $B0.20.50.50.61.12.9−1.13.5−1.3−6.83.9
EPS, diluted $−1.861.680.9411.7511.89−4.010.674.962.153.526.15
Dividend / sh $1.431.521.441.321.201.202.164.565.281.841.72
Payout %−77901541110−30323912935729
ROE %−4.23.01.722.119.9−7.40.74.01.816.629.4
Shares out B◌◌◌◌◌0.730.740.780.780.41◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 45 reconciliationsAUDITED

Reconciled in 11 of the 11 fiscal years we could check. 16 checks were skipped: the balance sheet is not tagged before 2015. Eight checks were skipped: EPS is not tagged before 2015. Eight checks were skipped: revenue is not tagged before 2015.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityPlastic Materials, Synth Resins & Nonvulcan Elastomers
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2015

Share this section

Download image